Novo Nordisk has multiple weight-loss drugs in various stages of development and approval, according to its R&D pipeline. These include, among others, monlunabant (phase 2); oral and subcutaneous ...

Ecnoglutide is distinguished by its selective activation of the cAMP signalling pathway, reducing β-arrestin recruitment.

Lean Drops, an innovative liquid dietary supplement targeting metabolic function and appetite regulation, has officially ...

The drugs have names that sound like small planets: semaglutide, liraglutide, lixisenatide. Collectively, they belong to a class of glucagon-like peptide 1 (GLP-1) analogs that has reshaped the ...

Taking magnesium with a GLP-1 like Ozempic? Learn how they can interact, potential digestive effects, and key safety tips.

Preclinical studies in animals have already shown that GLP-1 drugs can reduce reward-seeking behavior. Early clinical work in humans has begun to hint at similar effects. A randomized trial of ...

Researchers map the peptide behind semaglutide across 25 brain regions in each sex, finding striking differences in ...

CDSCO issues advisory against promotional activities for anti-obesity, metabolic disorder drugs: Our Bureau, New Delhi Thursday, March 12, 2026, 12:45 Hrs [IST] The Central Drugs ...

Recent studies have linked glucagon-like peptide-1 (GLP-1) receptor agonistTrusted Source medications, such ...

Researchers create the first sex-specific GLP-1 brain atlas, revealing why weight-loss drugs work differently in men and women.

Researchers have pinpointed a key regulator behind how GLP-1 drugs promote viability and stress resistance in pancreatic beta ...

Wegovy is a Food and Drug Administration-approved weight loss medication for people with obesity or those who are overweight with weight-related health conditions. In recent years, interest in ...